Clinical trials
Phase 3 Endocrine System Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Active, not recruiting | 4 |
| Recruiting | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 6 |
| AstraZeneca | 5 |
| Ascendis Pharma Endocrinology Division A/S | 4 |
| Ascendis Pharma A/S | 2 |
| Ascendis Pharma Bone Diseases A/S | 2 |
| Pfizer | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Celgene | 1 |
| Denver Health and Hospital Authority | 1 |
| Orexigen Therapeutics, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocrine System Diseases | 26 |
| Glucose Metabolism Disorders | 15 |
| Metabolic Diseases | 15 |
| Diabetes Mellitus, Type 2 | 14 |
| Diabetes Mellitus | 12 |
| Dwarfism, Pituitary | 5 |
| Failure to Thrive | 5 |
| Body Weight | 3 |
| Hypoparathyroidism | 3 |
| Nutrition Disorders | 3 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.